Loading stock data…
Evaxion A/S (EVAX)
$2.96-0.09 (-2.95%)
Market ClosedLast close Jul 24
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Evaxion A/S in the Healthcare sector is trading at $2.96 with a market capitalization of $30M. Wall Street consensus targets $11.25 (4 analysts), implying a +280.1% move over the next 12 months. The stock is currently near its 52-week low of $2.45, remaining 33.0% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 25 is oversold, raising the odds of a near-term bounce. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +280.1% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 25) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0↓ | $7.49M↑ | $37,000 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$3.82M↑ | -$4.05M↓ | $3.02M↑ | -$4.34M↓ | -$3.87M |
| Net Income | -$3.63M↑ | -$5.92M↓ | $4.62M↑ | -$4.83M↓ | -$1.58M |
Peer Comparison
JNJUNHPFE
Fundamentals
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$30.19M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
7.30%
Volume
Today's trading volume
3,271
Recent News
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
European equities traded in the US as American depositary receipts were tracking modestly higher lat
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
European equities traded in the US as American depositary receipts were sharply higher late Thursday
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Wednesday Trading
European equities traded in the US as American depositary receipts were tracking sharply lower late
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
European equities traded in the US as American depositary receipts were trending higher late Monday
European Equities Traded in US as ADRs Rise in Thursday Trading
European equities traded in the US as American depositary receipts rose late Thursday morning with t